Douglas Rosenthal Biography
Douglas Rosenthal was born in 1965 in Cleveland, Ohio, where he finished elementary school and high school. Douglas Rosenthal is a Ph.D. candidate in genetics and bioengineering at Case Western Reserve University. His innovation will be found in March at an international competition in Berlin.
Rosenthal likes to talk about finding a cure, his interest in medicine, other projects in the medical field he is working on, but also about future plans and goals.
Rosenthal had an interest in medicine from a young age. But there was a time when medicine and the natural sciences didn't really interest him, until he enrolled in medical high school and got a chance to see the connection between those basic sciences, which were often very interesting but boring to him, into something fascinating.
Rosenthal's Scientific Discovery
A cure for cancer could be Rosenthal's scientific discovery. For him, it's about applying one type of nanotechnology, biodegradable and naturally occurring in all complex cells, in the treatment of two types of tuberculosis. With his new method, both forms of tuberculosis are predicted to be curable.
At the moment Rosenthal has a lot of support from his university, but given the intensity of the financial and technological support needed, he is currently in talks with certain investors, so the paper will certainly be presented at probably the biggest scientific conference of the year in front of just those people who are in this kind of stuff they have the most interest and give the biggest roles.
Essentially, the drug needs to be tested. At the same time, patenting of this drug and its variations that Rosenthal is going to test, is ongoing. Bioinformatics has been used to predict how a drug will behave in the human body and what effects it will have, but currently, our understanding of how tuberculosis bacillus behaves in the human body is not complete. It is very important to synthesize and test this drug, given that it uses technology that can be modified as needed.
Rosenthal has always been of the opinion that tuberculosis is a disease of the past or, a disease of countries that cannot afford treatment. But he learned that he was wrong. Until three years ago, he was unaware that WHO had put eradication of tuberculosis under one of its goals, along with HIV. The plan was to eradicate tuberculosis by 2020, but that clearly will not happen. Resistant tuberculosis is on the rise, and there are strains that are resistant to all medicines. The reason is that this is one fascinating pathogen that we have only begun to learn about in the last 10 years.
Currently, Rosenthal works on several projects. With a team of pathologists, molecular biologists and geneticists, he is working on research into Alzheimer's disease, using laboratory mice. He does these two projects in parallel, and the essence is to test the effect of certain compounds we come in contact with on a daily basis, on the central nervous system. However, this study has only just begun and is very interdisciplinary. The results of this study may be polarizing, but his mission is to uncover objective truth.
His innovation will be found in March at an international competition in Berlin. That is a unique opportunity for young researchers in technology and society. The point of this conference and the final competition is to bring innovators together with those who have the means to turn those ideas into reality. Many call this conference the best science event of the year because it simply brings together only those people who work on the science front. It is a huge honor for Douglas Rosenthal to be selected to be in that competition for those four days in March.
Rosenthal is currently focused on is finding a university/institute that has the capacity needed for someone to do what he personally does. He plans to finish his Ph.D. studies, and continue to build an academic career in the study of stem cells, neuro-degeneration and the application of nano-physics in medicine.